Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114089486 | 11408948 | 6 | F | 20140327 | 20160819 | 20150824 | 20160825 | EXP | CA-ROCHE-1622901 | ROCHE | 51.50 | YR | F | Y | 0.00000 | 20160826 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 114089486 | 11408948 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | UNKNOWN | 103976 | 225 | MG | SOLUTION FOR INJECTION | QOW | |||||
| 114089486 | 11408948 | 2 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | UNKNOWN | 103976 | SOLUTION FOR INJECTION | ||||||||
| 114089486 | 11408948 | 3 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | UNKNOWN | 103976 | SOLUTION FOR INJECTION | ||||||||
| 114089486 | 11408948 | 4 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | UNKNOWN | 103976 | SOLUTION FOR INJECTION | ||||||||
| 114089486 | 11408948 | 5 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | UNKNOWN | 103976 | SOLUTION FOR INJECTION | ||||||||
| 114089486 | 11408948 | 6 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | UNKNOWN | 103976 | SOLUTION FOR INJECTION | ||||||||
| 114089486 | 11408948 | 7 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | UNKNOWN | 103976 | SOLUTION FOR INJECTION | ||||||||
| 114089486 | 11408948 | 8 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | UNKNOWN | 103976 | SOLUTION FOR INJECTION | ||||||||
| 114089486 | 11408948 | 9 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | UNKNOWN | 103976 | SOLUTION FOR INJECTION | ||||||||
| 114089486 | 11408948 | 10 | SS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | UNKNOWN | 103976 | SOLUTION FOR INJECTION | ||||||||
| 114089486 | 11408948 | 11 | C | VENTOLINE | ALBUTEROL | 1 | Unknown | 6 TIMES IN ONE DAY | 0 | ||||||||||
| 114089486 | 11408948 | 12 | C | ALVESCO | CICLESONIDE | 1 | Unknown | 2 INHALATIONS | 0 | 200 | UG | BID | |||||||
| 114089486 | 11408948 | 13 | C | SINGULAIR | MONTELUKAST SODIUM | 1 | 0 | ||||||||||||
| 114089486 | 11408948 | 14 | C | ADVAIR HFA | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Unknown | 0 | 250 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 114089486 | 11408948 | 1 | Asthma |
| 114089486 | 11408948 | 11 | Hypersensitivity |
| 114089486 | 11408948 | 12 | Product used for unknown indication |
| 114089486 | 11408948 | 13 | Product used for unknown indication |
| 114089486 | 11408948 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 114089486 | 11408948 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 114089486 | 11408948 | Alopecia | |
| 114089486 | 11408948 | Anaphylactic shock | |
| 114089486 | 11408948 | Anxiety | |
| 114089486 | 11408948 | Aphonia | |
| 114089486 | 11408948 | Asthenia | |
| 114089486 | 11408948 | Asthma | |
| 114089486 | 11408948 | Atelectasis | |
| 114089486 | 11408948 | Back pain | |
| 114089486 | 11408948 | Blood pressure systolic increased | |
| 114089486 | 11408948 | Breast mass | |
| 114089486 | 11408948 | Breath sounds abnormal | |
| 114089486 | 11408948 | Contusion | |
| 114089486 | 11408948 | Depressed mood | |
| 114089486 | 11408948 | Depression | |
| 114089486 | 11408948 | Diarrhoea | |
| 114089486 | 11408948 | Discomfort | |
| 114089486 | 11408948 | Drug hypersensitivity | |
| 114089486 | 11408948 | Dysgeusia | |
| 114089486 | 11408948 | Dyspnoea | |
| 114089486 | 11408948 | Fatigue | |
| 114089486 | 11408948 | Feeling hot | |
| 114089486 | 11408948 | Hyperhidrosis | |
| 114089486 | 11408948 | Hypoaesthesia | |
| 114089486 | 11408948 | Influenza | |
| 114089486 | 11408948 | Insomnia | |
| 114089486 | 11408948 | Intervertebral disc protrusion | |
| 114089486 | 11408948 | Lymph node pain | |
| 114089486 | 11408948 | Lymphadenopathy | |
| 114089486 | 11408948 | Malaise | |
| 114089486 | 11408948 | Memory impairment | |
| 114089486 | 11408948 | Migraine | |
| 114089486 | 11408948 | Musculoskeletal pain | |
| 114089486 | 11408948 | Myalgia | |
| 114089486 | 11408948 | Nasal discharge discolouration | |
| 114089486 | 11408948 | Nasal obstruction | |
| 114089486 | 11408948 | Nasopharyngitis | |
| 114089486 | 11408948 | Nausea | |
| 114089486 | 11408948 | Nervousness | |
| 114089486 | 11408948 | Nightmare | |
| 114089486 | 11408948 | Oral mucosal eruption | |
| 114089486 | 11408948 | Pain | |
| 114089486 | 11408948 | Pyrexia | |
| 114089486 | 11408948 | Rales | |
| 114089486 | 11408948 | Respiratory rate increased | |
| 114089486 | 11408948 | Stomach mass | |
| 114089486 | 11408948 | Stress | |
| 114089486 | 11408948 | Traumatic lung injury | |
| 114089486 | 11408948 | Wound | |
| 114089486 | 11408948 | Wound complication |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 114089486 | 11408948 | 1 | 20140327 | 0 | ||
| 114089486 | 11408948 | 2 | 20140424 | 0 | ||
| 114089486 | 11408948 | 3 | 20140522 | 0 | ||
| 114089486 | 11408948 | 4 | 20140605 | 0 | ||
| 114089486 | 11408948 | 5 | 20140717 | 0 | ||
| 114089486 | 11408948 | 6 | 20141106 | 0 | ||
| 114089486 | 11408948 | 7 | 20141230 | 0 | ||
| 114089486 | 11408948 | 8 | 20150115 | 0 | ||
| 114089486 | 11408948 | 10 | 20160114 | 0 |